Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytidine and Creatine in Bipolar Depression
NCT01543139Phase 2Withdrawn
- Sponsor
- Ewha Womans University
- Start
- Dec 2015
- Primary completion
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cytidine, creatine in bipolar disorder (BD), sponsored by Ewha Womans University. Planned start Dec 2015; status: withdrawn.
02
Drugs
Cytidinecreatine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01543139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543139.